Dr. Sameer Jejurikar is an Award Winning Leader in Plastic Surgery

Dr. Sameer Jejurikar is a plastic surgeon who specializes in cosmetic surgeries such as breast augmentation, tummy tucks, facelifts and much more. Dr. Jejurikar received a special recognition in 2013 when he received the Patients’ Choice Compassionate Doctor Certification.

Only 3% of the approximately 870,000 doctors nationwide received the honor that year. To qualify doctors must receive nearly perfect overall and bedside manner scores on surveys completed by their patients on sites such as UCompareHealthCare, Patients’ Choice, and Vitals.

Dr. Sameer Jejurikar completed his undergraduate studies at the University of Michigan where he was also part of the Alpha Omega Alpha Honor Society. Upon completion of his studies, he completed his plastic surgery residency at the same university.

He then extended his studies into the subspecialty of aesthetic surgery at the Manhattan Eye, Ear, and Throat Hospital. Dr. Jejurikar is currently a member of several organizations including the American Society of Aesthetic Plastic Surgery and the Dallas Society of Plastic Surgeons.

Dr. Sameer Jejurikar is currently affiliated with 8 hospitals in the Dallas area. These affiliations include the Baylor University Medical Center, Dallas Day Surgery Center, Forest Park Medical Center, Pine Creek Medical Center and Texas Health Presbyterian Hospital in Dallas. He is also affiliated with Baylor Surgicare at Ennis in Ennis Texas, Forest Park Medical Center in Frisco, and the Medical Center of Plano in Plano Texas.

Dr. Sameer Jejurikar has over a decade of experience in his field and offers free online cosmetic consultations as well as free consultations in hi Dallas and Plano based offices.

Mikhail Blagosklonny and his Successful Career

Mikhail Blagoslonny is a professor at the Roswell Park Cancer Institute. Here he carries out extensive research on cancer and aging which are critical areas of study in the modern world. The scientist, who resides in New York, is also oncology professor at the same institution. Blagosklonny is a talented scientist who has a rich educational background. He studied internal medicine and enrolled for a doctorate because of his desire to excel in the field of research. He studied cardiology and medicine, fields which are essential for its area of interest.

After doing a doctorate, he got an appointment at the New York Medical College where he started serving as an associate professor in the field of medicine. He served the college until in 2002 when he went to Ordway, which is a research institute. Here, he held a position of senior scientist and continued to gain experience which led him to get a position as an oncology professor at Roswell Park Cancer Insititute. The institution is well-known for working with scientists to discover ways of helping cancer patients. Through their extensive research, they have found some ways of helping cancer patients. View Mikhail’s profile on Loop

The institution has every belief that Mikhail Blagosklonny has all it takes to help it in teaching students who are passionate about oncology. Through this position, Blogosklonny has worked with other researchers and students. Mikhail is always ready to work with others and help students understand the field so as to become future scientists. At the institution, Mikhail has played a significant role in making a breakthrough on cancer and aging. His primary focus is cancer therapies and protection of healthy cells. He is also focused on the mechanism that underly aging.

Mikhail is also known for the formulation of the hypothesis on TOR as a signal for aging. The theory claims that TOR signaling is a key factor in cancer and aging. If the theory is correct, then drug such as rapamycin could be helpful in the treatment of cancer and extension of life. The scientist also carries out other endeavors such as editing. He works with Aging, Cell Cycle nd Oncotarget journals where he has significant contributions. Follow Mikhail on Google Scholar

Minimally Invasive Pulmonary Disease Treatments at the Lung Institute

The Lung Institute provides innovative stem cell treatment regimens to people suffering from different lung diseases, conditions, and ailments. The Lung Institute is becoming recognized as a leader in regenerative medicine.

The experienced, highly-regarded team of physicians at the Lung Institute are involved in providing revolutionary, minimally invasive stem cell treatments at assist in addressing a variety of pulmonary conditions and diseases. The treatment regiments undertaken at the Lung Institute are normally undertaken on an outpatient basis for most patients.

The Lung Institute utilizes a stem cell transplant process that utilizes what technically are known as autologous stem cells. According to the Baylor College of Medicine, these are combined with platelet-rich plasma as part of a comprehensive treatment process.

By utilizing autologous stem cells, patients of the Lung Institute enjoy a higher treatment success rate. Autologous stem cells means that the stem cells utilized in treating a person with a lung condition actually are drawn from that person’s body initially.

Indeed, for most people, there exist no appreciable side effects when treatment at the Lung Institute for a pulmonary issue.

The treatment protocol at Lung Institute is demonstrating itself to be more effective than what is available through other therapeutic regimens. Not only does the treatment and therapy offered through the Lung Institute help to alleviate the symptoms of certain lung conditions, it also appears to slow the advance of a lung disease or condition.

An individual afflicted with a pulmonary condition can schedule a no obligation and no cost appointment with the team at the Lung Institute. A person can obtain information about the different treatment options available to a patient. A preliminary consultation can be at a time convenient to a person investigating his or her options in regard to treating lung disease.

To learn more about Lung Institute, see supplementpolice.com.

Follow the Lung Institute: https://twitter.com/lunginstitute?lang=en